Co-Diagnostics (CODX) Misses Q1 EPS by 10c

Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• China semiconductor equipment imports grow 9% in July, Barclays comments
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance